PHILADELPHIA (MedPage Today) -- Survival in idiopathic pulmonary fibrosis (IPF) improved significantly in patients treated with proton pump inhibitors (PPIs), adding to a body of evidence supporting PPI benefits in IPF, investigators in a retrospective review concluded. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment